Fortress Biotech Inc
FBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$59.22M
Close$
$-3.09
265.4% downside
Current Fair Value
265.4% downsideOvervalued by 265.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $59.22 Million |
|---|---|
| Enterprise Value | $-78,864,486.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.07 |
| Beta | 1.25 |
| Outstanding Shares | 31,666,585 |
Return
| Return on Equity | 64.01% |
|---|---|
| Return on Assets | 33.17% |
| Return on Invested Capital | -15.70% |
Valuation & Multiples
| P/E Ratio | 0.65 |
|---|---|
| PEG | -0.63 |
| Price to Sales | 0.94 |
| Price to Book Ratio | 0.31 |
| Enterprise Value to Revenue | 0.03 |
| Enterprise Value to EBIT | -0.06 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 24.79 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
$19.41 M
Average shareholder expectationNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
$-0.27
Average shareholder expectationRevenue Estimate
$21.57 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 9.7118▼ 2023.90% |
|---|---|
| Total Calls | 45,800▲ 275.41% |
| Total Puts | 444,800▲ 21.73% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 18.29%▲ 1.30% |
|---|---|
| Total Invested | $17.73M▲ 18.56% |
| Investors Holding | 60▲ 3.00% |
ESG Score
No data
About Fortress Biotech Inc
111 employees
CEO: Lindsay Rosenwald